Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
3(18%)
Results Posted
8%(1 trials)

Phase Distribution

Ph phase_2
3
18%
Ph early_phase_1
1
6%
Ph phase_1
12
71%
Ph not_applicable
1
6%

Phase Distribution

13

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
1(5.9%)
Phase 1Safety & dosage
12(70.6%)
Phase 2Efficacy & side effects
3(17.6%)
N/ANon-phased studies
1(5.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(3)
Completed(13)
Other(1)

Detailed Status

Completed13
Recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.9%)
Phase 112 (70.6%)
Phase 23 (17.6%)
N/A1 (5.9%)

Trials by Status

unknown16%
completed1376%
recruiting318%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07301632Phase 2

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial

Recruiting
NCT04264026Phase 2

MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD

Completed
NCT06884514Phase 1

Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects

Recruiting
NCT05790239Phase 2

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Recruiting
NCT05523401Phase 1

Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects

Completed
NCT04847206Phase 1

Effects of MDMA-like Substances in Healthy Subjects

Completed
NCT05277636Phase 1

Acute Effects of R- and S-MDMA in Healthy Subjects

Completed
NCT03790618Phase 1

Effect of Stimulant Drugs on Social Perception

Completed
NCT04516902Phase 1

Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects

Completed
NCT05488171Phase 1

Abuse Potential and Human Pharmacology of Methylone

Unknown
NCT01270672Not Applicable

Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)

Completed
NCT01386177Phase 1

Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)

Completed
NCT01616407Early Phase 1

Effects of MDMA and Methylphenidate on Social Cognition

Completed
NCT01465685Phase 1

Emotional Effects of Methylphenidate and MDMA in Healthy Subjects

Completed
NCT02232789Phase 1

Abuse Liability and Human Pharmacology of Mephedrone

Completed
NCT00990067Phase 1

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

Completed
NCT01136278Phase 1

Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17